Did Use Of Ivermectin In Latin America Sabotage Clinical Trials and Confuse The World Of Medicine?
, A., Do Your Own Research (Preprint) (meta analysis)
, Did Use Of Ivermectin In Latin America Sabotage Clinical Trials and Confuse The World Of Medicine?, , A., Do Your Own Research (Preprint) (meta analysis)
Meta analysis of ivermectin trials showing community use of ivermectin in Latin America associated with lower observed efficacy in trials, consistent with the side effect profiles, Google Trends analysis, and investigator statements.Author uses the same trials as [Bitterman], finding a much stronger association than with strongyloides (which does not match the extended data set [ivmmeta.com] or expectations for the effect of strongyloides on the trial results [doyourownresearch.substack.com]).Currently there are 95 ivermectin studies and meta analysis shows:
| Outcome | Improvement |
|---|---|
| Mortality | 51% lower [37‑62%] |
| Ventilation | 29% lower [13‑42%] |
| ICU admission | 41% lower [16‑58%] |
| Hospitalization | 34% lower [20‑45%] |
| Cases | 78% fewer [67‑85%] |
1.
Bitterman et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2022.3079,
Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis,
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790173.
Marinos et al., 27 Sep 2022, preprint, 1 author.
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.